Boyang Bian

502 total citations
19 papers, 372 citations indexed

About

Boyang Bian is a scholar working on Economics and Econometrics, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Boyang Bian has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 5 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Boyang Bian's work include Pharmaceutical Economics and Policy (5 papers), Asthma and respiratory diseases (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Boyang Bian is often cited by papers focused on Pharmaceutical Economics and Policy (5 papers), Asthma and respiratory diseases (5 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Boyang Bian collaborates with scholars based in United States and China. Boyang Bian's co-authors include Jeff J. Guo, Christina M.L. Kelton, Dennis W. Raisch, John Doyle, Y. Lis, Patricia R. Wigle, Pamela C. Heaton, Katherine Tsai, Kaan Tunceli and Phil Schwab and has published in prestigious journals such as Neurology, Obesity and Value in Health.

In The Last Decade

Boyang Bian

16 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyang Bian United States 9 107 70 63 62 42 19 372
Sipke T. Visser Netherlands 15 82 0.8× 35 0.5× 96 1.5× 22 0.4× 51 1.2× 28 641
Yu-Wen Wen Taiwan 15 136 1.3× 39 0.6× 37 0.6× 46 0.7× 17 0.4× 24 659
Eliana Vieira Santucci Brazil 8 69 0.6× 83 1.2× 57 0.9× 34 0.5× 65 1.5× 16 390
T. Nicholson United Kingdom 7 163 1.5× 40 0.6× 17 0.3× 96 1.5× 44 1.0× 9 471
Victor Crentsil United States 9 81 0.8× 55 0.8× 9 0.1× 43 0.7× 23 0.5× 16 421
Joel C. Marrs United States 16 70 0.7× 30 0.4× 135 2.1× 22 0.4× 25 0.6× 58 577
Mariana Catapano Italy 14 106 1.0× 74 1.1× 14 0.2× 22 0.4× 30 0.7× 20 565
L. Martínez France 12 33 0.3× 30 0.4× 179 2.8× 32 0.5× 58 1.4× 30 448
Steven Shea United States 11 41 0.4× 72 1.0× 43 0.7× 13 0.2× 89 2.1× 15 560
Jens‐Ulrik Rosholm Denmark 11 37 0.3× 22 0.3× 24 0.4× 38 0.6× 24 0.6× 17 349

Countries citing papers authored by Boyang Bian

Since Specialization
Citations

This map shows the geographic impact of Boyang Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyang Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyang Bian more than expected).

Fields of papers citing papers by Boyang Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyang Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyang Bian. The network helps show where Boyang Bian may publish in the future.

Co-authorship network of co-authors of Boyang Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Boyang Bian. A scholar is included among the top collaborators of Boyang Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyang Bian. Boyang Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Zeitler, Emily P., Boyang Bian, Robert I. Griffiths, et al.. (2024). Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries. Circulation Cardiovascular Quality and Outcomes. 17(10). e011007–e011007.
4.
Li, Tianyang, Boyang Bian, Ru‐Rong Ji, et al.. (2024). Polyethylene Terephthalate Microplastic Exposure Induced Reproductive Toxicity Through Oxidative Stress and p38 Signaling Pathway Activation in Male Mice. Toxics. 12(11). 779–779. 8 indexed citations
5.
Guo, Chu‐Yueh, Sylvia Klineova, Jong‐Mi Lee, et al.. (2024). Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates (P4-6.005). Neurology. 102(7_supplement_1). 6308–6308.
6.
Yu, Shengsheng, Phil Schwab, Boyang Bian, Larry Radican, & Kaan Tunceli. (2016). Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study. Journal of Managed Care & Specialty Pharmacy. 22(3). 272–280. 18 indexed citations
7.
Kelton, Christina M.L., et al.. (2015). Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010. Obesity. 23(8). 1721–1728. 73 indexed citations
8.
Kelton, Christina M.L., et al.. (2014). Firm- and Drug-Specific Patterns of Generic Drug Payments by US Medicaid Programs: 1991–2008. Applied Health Economics and Health Policy. 12(2). 165–177. 8 indexed citations
9.
Xia, Ying, et al.. (2013). Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma. Therapeutic Advances in Drug Safety. 4(6). 254–263. 20 indexed citations
10.
Guo, Jing, et al.. (2012). PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients with Moderate and Severe Asthma. Value in Health. 15(4). A57–A57. 2 indexed citations
11.
Bian, Boyang, et al.. (2012). Long-Term Medicaid Excess Payments from Alleged Price Manipulation of Generic Lorazepam. Journal of Managed Care Pharmacy. 18(7). 506–515. 1 indexed citations
12.
Bian, Boyang, et al.. (2012). Utilization, Spending, and Price Trends for Benzodiazepines in the US Medicaid Program: 1991-2009. Annals of Pharmacotherapy. 46(4). 503–512. 23 indexed citations
13.
Guo, Jeff J., Katherine Tsai, Christina M.L. Kelton, Boyang Bian, & Patricia R. Wigle. (2011). Risk of serious asthma exacerbations associated with long-acting beta agonists among patients with asthma: A retrospective cohort study. Annals of Allergy Asthma & Immunology. 106(3). 214–222.e2. 25 indexed citations
14.
Bian, Boyang, et al.. (2011). Evidence-Based Prediction of Statin Use with Lipid-Panel Data from the National Health and Nutrition Examination Survey. Value in Health. 15(1). 32–38. 3 indexed citations
15.
Bian, Boyang, Christina M.L. Kelton, Patricia R. Wigle, & Jeff J. Guo. (2010). Evaluating Safety of Long-Acting Beta Agonists (LABAs) in Patients with Asthma. Current Drug Safety. 5(3). 245–250. 8 indexed citations
16.
17.
18.
Bian, Boyang, Christina M.L. Kelton, Jeff J. Guo, & Patricia R. Wigle. (2010). ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008. Journal of Managed Care Pharmacy. 16(9). 671–679. 29 indexed citations
19.
Bian, Boyang, et al.. (2010). PRS5 EVALUATING SAFETY OUTCOMES OF LONG-ACTING BETA AGONISTS (LABAS) IN PATIENTS WITH ASTHMA. Value in Health. 13(7). A561–A561. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sipke T. Visser Breakdown of academic impact, for papers by Yu-Wen Wen Breakdown of academic impact, for papers by Eliana Vieira Santucci Breakdown of academic impact, for papers by T. Nicholson Breakdown of academic impact, for papers by Victor Crentsil Breakdown of academic impact, for papers by Joel C. Marrs Breakdown of academic impact, for papers by Mariana Catapano Breakdown of academic impact, for papers by L. Martínez Breakdown of academic impact, for papers by Steven Shea Breakdown of academic impact, for papers by Jens‐Ulrik Rosholm
Rankless by CCL
2026